Understanding the Effects of Intervention on the Brain in Autism
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02680015|
Recruitment Status : Recruiting
First Posted : February 11, 2016
Last Update Posted : December 10, 2018
|Condition or disease||Intervention/treatment||Phase|
|Autism Spectrum Disorder Asperger Disorder PDD-NOS Autism||Behavioral: PEERS||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||400 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Care Provider, Investigator)|
|Official Title:||Understanding the Effects of Intervention on the Brain in Autism|
|Study Start Date :||August 2010|
|Estimated Primary Completion Date :||December 2025|
|Estimated Study Completion Date :||December 2025|
Experimental: Experimental Group
Immediate enrollment in the PEERS group.
Social-behavioral intervention designed to help individuals with Autism Spectrum Disorder make and keep friends.
Other Name: Program for the Education and Enrichment of Relational Skills
No Intervention: Waitlist Group
Research measures while waiting for PEERS; will receive PEERS within one year.
- Social Responsiveness Scale (SRS: Constantino, 2005) [ Time Frame: within two weeks of PEERS completion ]Questionnaire completed by caregivers on social function and autism symptoms. Will be aggregated by group; no individual reports will be used.
- Test of Adolescent Social SKills (TASSK: Laugeson & Frankel, 2010) [ Time Frame: within two weeks of PEERS completion ]Questionnaire completed by participants with Autism Spectrum Disorder. Measures knowledge of the PEERS intervention concepts. Will be aggregated by group; no individual reports will be used.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02680015
|Contact: Amy V Van Hecke, PhDemail@example.com|
|Contact: Hillary Schiltz, MSfirstname.lastname@example.org|
|United States, Wisconsin|
|Milwaukee, Wisconsin, United States, 53233|
|Contact: Alana McVey, MS 414-288-4438 email@example.com|
|Principal Investigator:||Amy Van Hecke, PhD||Marquette University|